Impact of the COVID‐19 pandemic on care disruptions, outcomes, and costs in patients receiving pulmonary arterial hypertension‐specific therapy in the United States of America: An observational study

Regular expert follow‐up, risk assessment, and early therapeutic intervention minimize worsening of pulmonary arterial hypertension (PAH). COVID‐19 lockdown measures were challenging for chronic disease management. This retrospective, longitudinal analysis used US claims data (January 12, 2016 to Se...

Descripción completa

Detalles Bibliográficos
Autores principales: George, Marjorie Patricia, Germack, Hayley D., Goyal, Amit, Ward, Charlotte, Studer, Sean, Panjabi, Sumeet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493079/
https://www.ncbi.nlm.nih.gov/pubmed/37701141
http://dx.doi.org/10.1002/pul2.12283

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10493079/
https://www.ncbi.nlm.nih.gov/pubmed/37701141
http://dx.doi.org/10.1002/pul2.12283

Ejemplares similares